Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer
Phase II Study of Danazol in Advanced or Recurrent Endometrial Cancer
2 other identifiers
interventional
N/A
2 countries
73
Brief Summary
RATIONALE: Hormone therapy may be an effective treatment for endometrial cancer. PURPOSE: Phase II trial to study the effectiveness of danazol in treating patients with advanced or recurrent endometrial cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
73 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 1999
CompletedFirst Submitted
Initial submission to the registry
November 1, 1999
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2003
CompletedFirst Posted
Study publicly available on registry
June 25, 2004
CompletedJune 10, 2013
July 1, 2004
3.8 years
November 1, 1999
June 7, 2013
Conditions
Keywords
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Gynecologic Oncology Grouplead
- National Cancer Institute (NCI)collaborator
Study Sites (73)
University of Alabama Comprehensive Cancer Center
Birmingham, Alabama, 35294, United States
CCOP - Greater Phoenix
Phoenix, Arizona, 85006-2726, United States
USC/Norris Comprehensive Cancer Center
Los Angeles, California, 90033-0800, United States
Jonsson Comprehensive Cancer Center, UCLA
Los Angeles, California, 90095-1781, United States
Chao Family Comprehensive Cancer Center
Orange, California, 92868, United States
Women's Cancer Center
Palo Alto, California, 94304, United States
University of Colorado Cancer Center
Denver, Colorado, 80262, United States
Vincent T. Lombardi Cancer Research Center, Georgetown University
Washington D.C., District of Columbia, 20007, United States
Walter Reed Army Medical Center
Washington D.C., District of Columbia, 20307-5000, United States
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, 33612, United States
Emory University Hospital - Atlanta
Atlanta, Georgia, 30322, United States
MBCCOP - Hawaii
Honolulu, Hawaii, 96813, United States
MBCCOP - University of Illinois at Chicago
Chicago, Illinois, 60612-7323, United States
Rush-Presbyterian-St. Luke's Medical Center
Chicago, Illinois, 60612, United States
University of Chicago Cancer Research Center
Chicago, Illinois, 60637, United States
CCOP - Central Illinois
Decatur, Illinois, 62526, United States
CCOP - Evanston
Evanston, Illinois, 60201, United States
Indiana University Cancer Center
Indianapolis, Indiana, 46202-5265, United States
CCOP - Iowa Oncology Research Association
Des Moines, Iowa, 50309-1016, United States
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
Albert B. Chandler Medical Center, University of Kentucky
Lexington, Kentucky, 40536-0084, United States
Johns Hopkins Oncology Center
Baltimore, Maryland, 21287, United States
Medicine Branch
Bethesda, Maryland, 20892, United States
Radiation Oncology Branch
Bethesda, Maryland, 20892, United States
Tufts University School of Medicine
Boston, Massachusetts, 02111, United States
University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, 01655, United States
CCOP - Ann Arbor Regional
Ann Arbor, Michigan, 48106, United States
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
University of Minnesota Cancer Center
Minneapolis, Minnesota, 55455, United States
University of Mississippi Medical Center
Jackson, Mississippi, 39216-4505, United States
Keesler Medical Center - Keesler AFB
Keesler Air Force Base, Mississippi, 39534-2576, United States
CCOP - Kansas City
Kansas City, Missouri, 64131, United States
Washington University School of Medicine
St Louis, Missouri, 63110, United States
CCOP - Montana Cancer Consortium
Billings, Montana, 59101, United States
CCOP - Missouri Valley Cancer Consortium
Omaha, Nebraska, 68131, United States
CCOP - Southern Nevada Cancer Research Foundation
Las Vegas, Nevada, 89106, United States
Cooper Hospital/University Medical Center
Camden, New Jersey, 08103, United States
Cancer Center of Albany Medical Center
Albany, New York, 12208, United States
State University of New York Health Science Center at Brooklyn
Brooklyn, New York, 11203, United States
North Shore University Hospital
Manhasset, New York, 11030, United States
Memorial Sloan-Kettering Cancer Center
New York, New York, 10021, United States
University of Rochester Cancer Center
Rochester, New York, 14642, United States
State University of New York Health Sciences Center - Stony Brook
Stony Brook, New York, 11790-9832, United States
Lineberger Comprehensive Cancer Center, UNC
Chapel Hill, North Carolina, 27599-7295, United States
Duke Comprehensive Cancer Center
Durham, North Carolina, 27710, United States
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, 27157-1082, United States
Barrett Cancer Center, The University Hospital
Cincinnati, Ohio, 45219, United States
Ireland Cancer Center
Cleveland, Ohio, 44106-5065, United States
Cleveland Clinic Cancer Center
Cleveland, Ohio, 44195, United States
Arthur G. James Cancer Hospital - Ohio State University
Columbus, Ohio, 43210, United States
University of Oklahoma College of Medicine
Oklahoma City, Oklahoma, 73190, United States
CCOP - Sooner State
Tulsa, Oklahoma, 74136, United States
CCOP - Columbia River Program
Portland, Oregon, 97213, United States
Abington Memorial Hospital
Abington, Pennsylvania, 19001, United States
Milton S. Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, 19104, United States
Kimmel Cancer Center of Thomas Jefferson University - Philadelphia
Philadelphia, Pennsylvania, 19107, United States
Pennsylvania Hospital
Philadelphia, Pennsylvania, 19107, United States
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
CCOP - MainLine Health
Wynnewood, Pennsylvania, 19096, United States
Medical University of South Carolina
Charleston, South Carolina, 29425-0721, United States
CCOP - Greenville
Greenville, South Carolina, 29615, United States
CCOP - Upstate Carolina
Spartanburg, South Carolina, 29303, United States
CCOP - Baptist Cancer Institute
Memphis, Tennessee, 38117, United States
Brookview Research, Inc.
Nashville, Tennessee, 37203, United States
Simmons Cancer Center - Dallas
Dallas, Texas, 75235-9154, United States
University of Texas - MD Anderson Cancer Center
Houston, Texas, 77030, United States
CCOP - Scott and White Hospital
Temple, Texas, 76508, United States
Cancer Center, University of Virginia HSC
Charlottesville, Virginia, 22908, United States
University of Washington Medical Center
Seattle, Washington, 98195-6043, United States
Tacoma General Hospital
Tacoma, Washington, 98405, United States
NCIC-Clinical Trials Group
Kingston, Ontario, K7L 3N6, Canada
Toronto Sunnybrook Regional Cancer Centre
Toronto, Ontario, M4N 3M5, Canada
Related Publications (1)
Covens A, Brunetto VL, Markman M, Orr JW, Lentz SS, Benda J; Gynecologic Oncology Group. Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2003 Jun;89(3):470-4. doi: 10.1016/s0090-8258(03)00149-5.
PMID: 12798713RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Allan Covens, MD
Toronto Sunnybrook Regional Cancer Centre